Comparison between Eris Lifesciences IPO and Tejas Networks IPO.
Eris Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tejas Networks IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Eris Lifesciences IPO is up to ₹1,740.49 Cr whereas the issue size of the Tejas Networks IPO is up to ₹776.69 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of Tejas Networks IPO is ₹257.00 per share.
| Eris Lifesciences IPO | Tejas Networks IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹600.00 per share | ₹250.00 per share |
| Issue Price (Upper) | ₹603.00 per share | ₹257.00 per share |
| Issue Price (Final) | ₹603.00 per share | ₹257.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹60.00 per share | |
| Market Lot Size | 24 shares | 55 shares |
| Fresh Issue Size | 0 shares | 1,75,09,727 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹450.00 Cr |
| OFS Issue Size | 2,88,75,000 shares | 1,27,11,605 shares |
| OFS Issue Size (Amount) | up to ₹1,740.49 Cr | up to ₹326.69 Cr |
| Issue Size Total | 2,88,75,000 shares | 3,02,21,332 shares |
| Issue Size Total (Amount) | up to ₹1,740.49 Cr | up to ₹776.69 Cr |
Eris Lifesciences IPO opens on Jun 16, 2017, while Tejas Networks IPO opens on Jun 14, 2017. The closing date of Eris Lifesciences IPO and Tejas Networks IPO is Jun 20, 2017, and Jun 16, 2017, respectively.
| Eris Lifesciences IPO | Tejas Networks IPO | |
|---|---|---|
| Anchor Bid Date | Jun 15, 2017 | Jun 13, 2017 |
| Issue Open | Jun 16, 2017 | Jun 14, 2017 |
| Issue Close | Jun 20, 2017 | Jun 16, 2017 |
| Basis Of Allotment (Tentative) | Jun 23, 2017 | Jun 21, 2017 |
| Initiation of Refunds (Tentative) | Jun 27, 2017 | Jun 22, 2017 |
| Credit of Share (Tentative) | Jun 28, 2017 | Jun 23, 2017 |
| Listing date (Tentative) | Jun 29, 2017 | Jun 27, 2017 |
| Anchor Lockin End date 1 | Jul 23, 2017 | Jul 21, 2017 |
| Anchor Lockin End date 2 | Sep 21, 2017 | Sep 19, 2017 |
Eris Lifesciences IPO P/E ratio is , as compared to Tejas Networks IPO P/E ratio of .
| Eris Lifesciences IPO | Tejas Networks IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹8291.25 Cr. | ₹2301.38 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Eris Lifesciences IPO Retail Individual Investors (RII) are offered 28,72,500 shares while in Tejas Networks IPO retail investors are offered 28,72,500 shares. Qualified Institutional Buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 90,66,400 shares in Tejas Networks IPO.
| Eris Lifesciences IPO | Tejas Networks IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,29,26,250 shares | 1,35,99,600 shares |
| Market Maker Reservation | ||
| QIB | 86,17,500 shares | 90,66,400 shares |
| NII | 43,08,750 shares | 45,33,199 shares |
| RII | 28,72,500 shares | 30,22,133 shares |
| Employee | 1,50,000 shares | |
| Others | ||
| Total | 2,88,75,000 shares | 3,02,21,332 shares |
Eris Lifesciences IPO subscribed 3.29x in total, whereas Tejas Networks IPO subscribed 1.88x.
| Eris Lifesciences IPO | Tejas Networks IPO | |
|---|---|---|
| QIB (times) | 4.68x | 2.16x |
| NII (times) | 0.45x | 0.48x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.51x | 3.10x |
| Employee (times) | 0.86x | |
| Other (times) | ||
| Total (times) | 3.29x | 1.88x |
